Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00889031 · ClinicalTrials.gov registry record
Protocol to Obtain Blood Samples for Leukemia Research
A clinical trial, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- 187
- Enrollment target
NCT00889031: Completed study, sponsored by Dartmouth-Hitchcock Medical Center.
NCT00889031 is a clinical trial that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 187 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00889031 has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- 187 participants
- Enrollment target
Study Summary
The purpose of this study is to collect a blood sample in patients with Chronic Lymphocytic Leukemia (CLL).
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 187 participants |
| Start Date | 2009-04 |
| Est. Completion | 2018-03-09 |
What the finished NCT00889031 record still lists
NCT00889031 is an observational study that tracks outcomes without assigning an intervention. The registered 187 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT00889031 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00889031 about?
NCT00889031 is a clinical study titled "Protocol to Obtain Blood Samples for Leukemia Research". The purpose of this study is to collect a blood sample in patients with Chronic Lymphocytic Leukemia (CLL).
What is the current status of trial NCT00889031?
This trial is currently completed. The enrollment target is 187 participants. The study started on 2009-04. Estimated completion is 2018-03-09.
What interventions are being tested in trial NCT00889031?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT00889031?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06153251 · 187 participants · Phase 1
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
- NCT06254898 · 187 participants · NA
Use of Incentives for Stressful Medical Procedures
- NCT07062237 · 187 participants · NA
A Randomized Clinical Trial Comparing Embryo Euploidy Rates Following Ultrashort Versus Standard Abstinence
- NCT07217574 · 187 participants
Program in Oncology for Tribal Health Systems.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia